SGX is not really "the Singapore stock exchange" anymore, even though that is still how most retail investors think of it. Under CEO Loh Boon Chye, who has led the group since 2015, SGX has spent close to a decade deliberately turning itself into a multi-asset exchange group: cash equities, equity derivatives, fixed income, currencies and commodities (FICC), plus a growing data and connectivity business.

In FY2026, FICC alone made up roughly a quarter of group revenue, on the back of record commodity derivatives volumes and an FX franchise whose average daily volume climbed 33% to US$190 billion.

The clearest proof of mastery this year was how the group absorbed a weak patch. Equity derivatives revenue was flat despite contract volumes rising 6%, dragged down by currency effects and a shift toward lower-fee contracts.

A single-product exchange would have felt that directly in its bottom line. SGX did not, because cash equities and FICC more than made up the gap. That is what genuine diversification is supposed to do, and it is a decent sign that management understands where its growth is actually coming from rather than riding a single cycle.

CEO Loh Boon Chye summed up the year by pointing to "the strength of our multi-asset strategy that we've been executing over the past decade," framing it as building a business that is broader, more resilient and more global.

I would rather see a CEO articulate that kind of continuity than reach for a new buzzword every results call, and the FY2026 segment mix backs up what he is saying rather than just asserting it.

SGX's moat starts with something most companies never get: a regulatory franchise. It is the sole licensed securities exchange in Singapore, so no competitor can simply set up shop and list SGX-listed companies on a rival Singapore exchange.

That kind of structural monopoly is rare, and it is the base layer under everything else SGX does.

On top of that sits a genuine network effect. Once a derivatives contract becomes the reference price for a market, such as SGX's FTSE China A50 futures or its Nikkei 225 and MSCI Taiwan futures, traders keep coming back because that is where the liquidity already is.

Liquidity attracts liquidity, the same dynamic that keeps traders on the world's biggest exchanges rather than a cheaper but thinner alternative.

The moat is not absolute. SGX competes for order flow with other Asian derivatives venues, and parts of the trading world are drifting toward digital-asset platforms that did not exist a decade ago.

What keeps me comfortable is that brokers, clearing members and data vendors are all plumbed into SGX's clearing house and depository. Ripping that infrastructure out and rebuilding it elsewhere is not a decision anyone makes lightly, and that switching cost is worth almost as much as the regulatory monopoly itself.

The gap between reported and adjusted profit is mostly a S$15 million goodwill impairment in the Indices business flagged earlier in the year, tied to the underperforming Scientific Beta unit. Strip that out and underlying growth looks stronger than the reported headline number alone suggests.

Worth breaking down that 57-cent dividend. It is made up of an 11.5-cent base fourth-quarter dividend plus a 12.5-cent one-off special dividend that management funded from capital recycling gains rather than ongoing earnings.

The underlying run-rate dividend still grew at a healthy clip, but the 52% headline growth figure is flattered by a payout that will not repeat every year.

Cash equities did the heavy lifting this year, up 28% as securities daily average value surged 35% to an 18-year high of S$1.81 billion, likely helped by a stronger IPO pipeline and a generally risk-on mood in regional markets.

FICC added another S$55 million on record commodity derivatives volumes. Platform and data revenue, the steadiest and highest-margin slice of the business, grew a more modest 7%.

Receive bite-sized market updates and actionable stock ideas - so you stay informed without spending hours researching.

Capital allocation is where a lot of exchange operators get lazy, since the business throws off cash even without much effort. SGX's management has instead attached numbers to its promises.

It has committed to raising the base quarterly dividend by 0.25 cents every quarter through FY2028, targeting roughly a 12% compound annual growth rate in dividends over that stretch. That is a specific, scheduled commitment a shareholder can hold management to, not a vague "progressive dividend policy" line in a slide deck.

The special dividend this year tells a similar story. Rather than sit on the capital recycling gains or chase a large, ego-driven acquisition, management returned the money directly to shareholders. At the same time, FY2027 guidance points to expenses rising 6% to 8% and capital expenditure climbing to roughly S$100 million, aimed at platform modernisation and new capabilities including AI.

In other words, this is not a management team milking the business dry to fund dividends. It is paying out generously while still funding the multi-asset expansion that made Mastery and Moat score well in the first place.

Loh Boon Chye has now run SGX since 2015, and the FY2026 results read as the payoff of a strategy set in motion years ago rather than a new leadership team's first big swing. Lower key-person risk is a genuine, if underrated, part of the Management M.

This is the M where I slow down. SGX shares closed at S$24.30 on 11 September 2026, sitting near the top of a 52-week range of S$16.23 to S$25.69, with the stock's market capitalisation up roughly 46% over the past year.

At around 37 times trailing earnings and 31 times forward earnings, SGX is priced more like a growth compounder than a defensive dividend payer.

And here's the kicker: even after the 52% dividend jump, SGX's yield has not caught up with the share price. At S$24.30, the FY2026 payout of 57 cents works out to roughly 2.35%. That trails both its closest regional peer and the broader Singapore market, as the table below shows.

In plain terms, if you bought SGX purely for income today, you would be accepting a lower starting yield than a basket of Singapore blue chips through the STI ETF, or Hong Kong's own exchange operator, in exchange for a faster-growing but less certain future payout.

Sell-side consensus, 16 analysts covering the stock, currently rates it a Hold with a 12-month price target of about S$24.15, essentially flat to where the shares sit today. The market's own forecasters are not pricing in much further re-rating from here, at least not yet.

Yes. SGX pays dividends quarterly and just closed FY2026 with a total payout of 57 cents per share, up 52% from the prior year. Part of that increase came from a one-off special dividend, so the ongoing run-rate is lower than the full-year total implies.

At a share price of S$24.30 on 11 September 2026, the FY2026 payout of 57 cents works out to a yield of roughly 2.35%. Some data providers show a lower trailing yield, closer to 1.8%, because they calculate it off the last four declared quarterly amounts rather than the full-year total including the special dividend. Check a live quote before relying on either figure, since both the share price and payout can move.

SGX shares are SGX-listed and generally eligible for SRS investment through most Singapore brokers, the same way any other SGX-listed blue chip is. Confirm directly with your SRS-linked brokerage before investing, since eligibility rules can vary by platform.

SGX Group has appeared on the CPF Investment Scheme (CPFIS) list of approved counters at various points, but the list changes periodically. Check the current CPFIS-OA or CPFIS-SA approved securities list on the CPF Board's website before assuming eligibility.

SGX shares trade in board lots of 100 shares, so at a share price of S$24.30, the minimum outlay works out to roughly S$2,430 before brokerage fees and whatever commission your broker charges.

That is not a call I am making for you here. The business scores well on mastery, moat, metrics and management, but the valuation, at close to 37 times trailing earnings and near a 52-week high, leaves a thinner margin of safety than I would like. Whether that trade-off suits you depends on your own entry price, time horizon and how much you are already exposed to SGX-listed and Singapore financial names.